Efficacy of topical tofacitinib, a Janus kinase inhibitor, in the treatment of plaque psoriasis

被引：6
|
作者：
Bagherani, Nooshin [1 ]
Smoller, Bruce R. [2 ]
机构：
[1] Dr Nooshin Bagherans Off, Khoramshahr, Khuzestan Provi, Iran
[2] Univ Rochester, Sch Med & Dent, Dept Dermatol, Dept Pathol, Rochester, NY 14642 USA
来源：
DERMATOLOGIC THERAPY | 2017年 / 30卷 / 03期
关键词：
psoriasis; tofacitinib; treatment; CLINICAL-TRIAL;
D O I：
10.1111/dth.12467
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Efficacy, safety and patient-reported outcomes up to 52 weeks with tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomised, Phase 3 trials
    Papp, Kim
    Krueger, James
    Feldman, Steven
    Langley, Richard G. B.
    Tori, Hideshi
    Tyring, Stephen K.
    Tatulych, Svitlana
    Gupta, Pankaj
    Mebus, Charles
    Tan, Huaming
    Luo, Yingchun
    Mamolo, Carla
    Mallbris, Lotus
    Wolk, Robert
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S10 - S10
  • [22] The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis
    Hodge, J. A.
    Kawabata, T. T.
    Krishnaswami, S.
    Clark, J. D.
    Telliez, J. -B.
    Dowty, M. E.
    Menon, S.
    Lamba, M.
    Zwillich, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (02) : 318 - 328
  • [23] Treatment of recalcitrant atopic dermatitis with the oral Janus kinase inhibitor tofacitinib citrate
    Levy, Lauren L.
    Urban, Jennifer
    King, Brett A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 73 (03) : 395 - 399
  • [24] Tofacitinib, an Oral Janus Kinase Inhibitor: Perspectives in Dermatology
    Kostovic, Kresimir
    Gulin, Sandra J.
    Mokos, Zrinka B.
    Ceovic, Romana
    CURRENT MEDICINAL CHEMISTRY, 2017, 24 (11) : 1158 - 1167
  • [25] Concurrent bullous pemphigoid and plaque psoriasis successfully treated with Janus kinase inhibitor Baricitinib
    Xiao, Yue
    Xiang, Hongmei
    Li, Wei
    DERMATOLOGIC THERAPY, 2022, 35 (10)
  • [26] Topical corticosteroids in plaque psoriasis: a systematic review of efficacy and treatment modalities
    Castela, E.
    Archier, E.
    Devaux, S.
    Gallini, A.
    Aractingi, S.
    Cribier, B.
    Jullien, D.
    Aubin, F.
    Bachelez, H.
    Joly, P.
    Le Maitre, M.
    Misery, L.
    Richard, M-A
    Paul, C.
    Ortonne, J. P.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 : 36 - 46
  • [27] The efficacy of tofacitinib and a selective Janus kinase 1 inhibitor in dextran sulphate sodium colitis models
    De Vries, L.
    van Leeuwen-Hilbers, F.
    van Hamersveld, P.
    Ludbrook, V.
    D'Haens, G.
    De Jonge, W.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S99 - S99
  • [28] Integrated Efficacy Analysis of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients with Active Psoriatic Arthritis
    Nash, Peter
    Coates, Laura C.
    Fleischmann, Roy
    Papp, Kim
    Gomez-Reino, Juan J.
    Kanik, Keith S.
    Wang, Cunshan
    Wu, Joseph
    Hendrikx, Thijs
    Ports, William C.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [29] Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study
    Papp, K. A.
    Menter, A.
    Strober, B.
    Langley, R. G.
    Buonanno, M.
    Wolk, R.
    Gupta, P.
    Krishnaswami, S.
    Tan, H.
    Harness, J. A.
    BRITISH JOURNAL OF DERMATOLOGY, 2012, 167 (03) : 668 - 677
  • [30] The Efficacy of Tofacitinib and a Selective Janus Kinase 1 Inhibitor in Dextran Sulphate Sodium Colitis Models
    De Vries, Leonie C.
    van Leeuwen-Hilbers, Francisca W.
    van Hamersveld, Patricia
    Ludbrook, Valerie
    D'Haens, Geert R.
    De Jonge, Wouter
    GASTROENTEROLOGY, 2016, 150 (04) : S970 - S970
12345